Literature DB >> 9104975

Does the pulmonary autograft in the aortic position in adults increase in diameter? An echocardiographic study.

R B Hokken1, A J Bogers, M A Taams, M B Schiks-Berghourt, L A van Herwerden, J R Roelandt, E Bos.   

Abstract

OBJECTIVE: The objective of this study was to discern the fate of the pulmonary autograft diameter over time in adults and its relation to aortic regurgitation in the setting of aortic root replacement.
METHODS: From January 1989 to May 1995, 36 consecutive adult patients underwent aortic root replacement with a pulmonary autograft for aortic valve disease. The mean age of 20 male and 16 female patients was 29.1 years (range 19.3 to 52.1 years). The mean follow-up was 2.3 years (range 0.3 to 6.0 years). Two patients died in the hospital. One other patient had a second operation for stenosis at the distal suture line of the allograft in the pulmonary position. Pulmonary autograft anulus and sinus diameters were measured with epicardial echocardiography before (only anulus) and after cardiopulmonary bypass, with transthoracic echocardiography at hospital discharge, and with transesophageal echocardiography during follow-up.
RESULTS: The mean autograft anulus diameter did not increase immediately after cardiopulmonary bypass (mean diameter 26.2 mm before and 26.4 mm after cardiopulmonary bypass). The mean autograft sinus diameter after cardiopulmonary bypass was 36.5 mm. The mean autograft anulus diameter increased to 31.5 mm at follow-up, an increase of 5.1 mm (19%). The mean autograft sinus diameter increased to 43.9 mm at follow-up, an increase of 7.4 mm (20%). Fifty-nine percent of the anulus diameter increase and 40% of the sinus diameter increase was already reached at hospital discharge (7 to 10 days after the operation); the other part of the increase occurred during follow-up. Diameter increase was associated with neither the length of follow-up (follow-up less than 1 year compared with a longer follow-up) or severity of aortic regurgitation.
CONCLUSION: Pulmonary autograft anulus and sinus diameters increase the first year after aortic root replacement with a pulmonary autograft. This occurs rapidly within 10 days after the operation, with a further increase during follow-up, without causing significant aortic regurgitation at medium-term follow-up.

Entities:  

Mesh:

Year:  1997        PMID: 9104975     DOI: 10.1016/s0022-5223(97)70223-x

Source DB:  PubMed          Journal:  J Thorac Cardiovasc Surg        ISSN: 0022-5223            Impact factor:   5.209


  6 in total

1.  Excessive pulmonary autograft dilatation causes important aortic regurgitation.

Authors:  R B Hokken; J J M Takkenberg; L A van Herwerden; J R T C Roelandt; A J J C Bogers
Journal:  Heart       Date:  2003-08       Impact factor: 5.994

2.  Wall stresses of early remodeled pulmonary autografts.

Authors:  Yue Xuan; Edgardo Alonso; Alexander Emmott; Zhongjie Wang; Shalni Kumar; Francois-Pierre Mongeon; Richard L Leask; Ismail El-Hamamsy; Liang Ge; Elaine E Tseng
Journal:  J Thorac Cardiovasc Surg       Date:  2021-08-31       Impact factor: 5.209

3.  Range of Pulmonary Autograft Responses to Systemic Pressure Immediately After Ross Procedure.

Authors:  Andrew D Wisneski; Zhongjie Wang; Yue Xuan; Julius M Guccione; Liang Ge; Elaine E Tseng
Journal:  J Heart Valve Dis       Date:  2019

Review 4.  Aortopathy associated with congenital heart disease: A current literature review.

Authors:  Katrien Francois
Journal:  Ann Pediatr Cardiol       Date:  2015 Jan-Apr

Review 5.  Understanding Pulmonary Autograft Remodeling After the Ross Procedure: Stick to the Facts.

Authors:  Lucas Van Hoof; Peter Verbrugghe; Elizabeth A V Jones; Jay D Humphrey; Stefan Janssens; Nele Famaey; Filip Rega
Journal:  Front Cardiovasc Med       Date:  2022-02-09

6.  Primary and secondary aortopathy associated with adult congenital heart disease - retrospective study.

Authors:  Ingrid Schusterova; Alžbeta Banovcinova; Marianna Vachalcova; Marta Jakubova; Panagiotis Artemiou
Journal:  J Cardiothorac Surg       Date:  2020-09-10       Impact factor: 1.637

  6 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.